Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 EUCAST technical note on tigecycline.

× No keyword cloud information.

29 in total

Review 1. Clinical and economic impact of common multidrug-resistant gram-negative bacilli.

Authors: Christian G Giske; Dominique L Monnet; Otto Cars; Yehuda Carmeli
Journal: Antimicrob Agents Chemother Date: 2007-12-10 Impact factor: 5.191

2. High concentrations of manganese in Mueller-Hinton agar increase MICs of tigecycline determined by Etest.

Authors: Carlos Fernández-Mazarrasa; Olav Mazarrasa; Jorge Calvo; Asunción del Arco; Luis Martínez-Martínez
Journal: J Clin Microbiol Date: 2009-01-14 Impact factor: 5.948

3. Emergence of the 16S rRNA methylase RmtG in an extended-spectrum-β-lactamase-producing and colistin-resistant Klebsiella pneumoniae isolate in Chile.

Authors: Laurent Poirel; Jaime Labarca; Helia Bello; Maria Luisa Rioseco; Sandrine Bernabeu; Patrice Nordmann
Journal: Antimicrob Agents Chemother Date: 2013-10-28 Impact factor: 5.191

4. In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.

Authors: Chia-Ying Liu; Yu-Tsung Huang; Chun-Hsing Liao; Po-Ren Hsueh
Journal: Antimicrob Agents Chemother Date: 2008-05-12 Impact factor: 5.191

5. In vitro activity of tigecycline against multidrug-resistant Enterobacteriaceae isolates from a Belgian hospital.

Authors: R Naesens; J P Ursi; J Van Schaeren; A Jeurissen
Journal: Eur J Clin Microbiol Infect Dis Date: 2008-09-19 Impact factor: 3.267

6. Predominance of KPC-3 in a survey for carbapenemase-producing Enterobacteriaceae in Portugal.

Authors: Vera Manageiro; Eugénia Ferreira; Joana Almeida; Stephanie Barbosa; Constança Simões; Robert A Bonomo; Manuela Caniça
Journal: Antimicrob Agents Chemother Date: 2015-03-16 Impact factor: 5.191

7. Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system.

Authors: Tara Reddy; Teena Chopra; Dror Marchaim; Jason M Pogue; George Alangaden; Hossein Salimnia; Dina Boikov; Shiri Navon-Venezia; Robert Akins; Philip Selman; Sorabh Dhar; Keith S Kaye
Journal: Antimicrob Agents Chemother Date: 2010-03-08 Impact factor: 5.191

8. Investigation of in-vitro susceptibility of multidrug-resistant Acinetobacter baumannii strains isolated from clinical specimens to tigecycline.

Authors: Tekin Tas; Esra Kocoglu; Zafer Mengeloglu; Ozlem Bucak; Seyda Karabörk
Journal: Bosn J Basic Med Sci Date: 2013-11 Impact factor: 3.363

9. In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006.

Authors: C-Y Liu; C-L Lu; Y-T Huang; C-H Liao; P-R Hsueh
Journal: Eur J Clin Microbiol Infect Dis Date: 2009-09-08 Impact factor: 3.267

10. Susceptibility of clinical isolates of frequently encountered bacterial species to tigecycline one year after the introduction of this new class of antibiotics: results of the second multicentre surveillance trial in Germany (G-TEST II, 2007).

Authors: M Kresken; E Leitner; H Seifert; G Peters; C von Eiff
Journal: Eur J Clin Microbiol Infect Dis Date: 2009-03-19 Impact factor: 3.267